Gyon Technologies Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Gyon Technologies Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,500	Closed	-$180K	–	72
2022 Q4	$180K	Buy	+2,500	New	+$189K	0.07%	309
2022 Q3	–	Sell	-5,546	Closed	-$427K	–	384
2022 Q2	$427K	Sell	5,546 -1,065	-16%	-$81.1K	0.12%	196
2022 Q1	$483K	Buy	+6,611	New	+$444K	0.34%	100
2021 Q2	–	Sell	-10,057	Closed	-$635K	–	362
2021 Q1	$635K	Sell	10,057 -8,379	-45%	-$521K	0.28%	107
2020 Q4	$1.14M	Buy	18,436 +13,898	+306%	+$855K	0.39%	83
2020 Q3	$274K	Buy	+4,538	New	+$273K	0.22%	170
2020 Q1	–	Sell	-17,266	Closed	-$1.11M	–	113
2019 Q4	$1.11M	Buy	+17,266	New	+$989K	0.73%	51

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Gyon Technologies Capital Management's BMY Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 2,500 shares — an estimated $180K sold.

Gyon Technologies Capital Management first reported a position in BMY in Q4 2019 and held it in 7 quarters. The position peaked at $1.14M in Q4 2020. 2,541 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Gyon Technologies Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Gyon Technologies Capital Management sold 2,500 Bristol-Myers Squibb shares in Q1 2023, an estimated $180K.
Gyon Technologies Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 7 quarters.
Gyon Technologies Capital Management's Bristol-Myers Squibb position peaked at $1.14M in Q4 2020.
2,541 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.